GlassScriptPhysician profile
Mark William Vanderland
NPI 1427610237
$6,232.22
in general payments reported to CMS, 2019-2025
31 companies · $610 in 2025
The $610 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $257 · 2021: $646 · 2022: $418 · 2023: $1,710 · 2024: $1,840 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,003 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,003.14 |
| Education | $156.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $997.22 | 2019-2024 | Farxiga, Brilinta |
| Boston Scientific Corporation | $778.98 | 2019-2025 | Emblem Mri S-Icd, Latitude Communicator Power Supply, General - Therapies |
| Abiomed | $650.68 | 2022-2024 | Impella |
| Heartflow, INC. | $496.88 | 2023-2024 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $491.19 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $409.02 | 2019-2025 | |
| Medtronic, INC. | $289.52 | 2023-2025 | Micra, Mycarelink, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $262.79 | 2019-2022 | |
| Amgen INC. | $246.93 | 2024-2025 | Repatha |
| Pfizer INC. | $228.93 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $189.29 | 2020-2024 | Camzyos, Eliquis |
| Cvrx, INC. | $153.26 | 2024 | Barostim Neo System |
| Paratek Pharmaceuticals, INC. | $115.43 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $108.00 | 2023 | Inpefa |
| Portola Pharmaceuticals, LLC | $96.56 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $81.09 | 2023 | Bva-100 |
| Lantheus Medical Imaging, INC. | $78.25 | 2023 | Definity |
| Stryker Corporation | $74.24 | 2025 | Flowtriever |
| Shockwave Medical, INC | $64.55 | 2025 | |
| Genzyme Corporation | $60.64 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.47 | 2022-2024 | Jardiance |
| Abbott Laboratories | $48.19 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Perclose Prostyle |
| Kiniksa Pharmaceuticals International, Plc | $43.69 | 2024 | Arcalyst |
| Becton, Dickinson and Company | $37.34 | 2025 | |
| Chiesi USA, INC. | $34.31 | 2025 | Cleviprex, Kengreal |
| Kiniksa Pharmaceuticals, LTD. | $33.30 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $30.28 | 2024 | Hemosphere |
| Penumbra, INC. | $24.83 | 2023 | Indigo System |
| Scpharmaceuticals INC. | $22.98 | 2025 | |
| Terumo Medical Corporation | $20.83 | 2024 | Angio-Seal |
| Celgene Corporation | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Vanderland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.